206 related articles for article (PubMed ID: 18767163)
1. Binding specificity of SH2 domains: insight from free energy simulations.
Gan W; Roux B
Proteins; 2009 Mar; 74(4):996-1007. PubMed ID: 18767163
[TBL] [Abstract][Full Text] [Related]
2. Hierarchy of simulation models in predicting molecular recognition mechanisms from the binding energy landscapes: structural analysis of the peptide complexes with SH2 domains.
Verkhivker GM; Bouzida D; Gehlhaar DK; Rejto PA; Schaffer L; Arthurs S; Colson AB; Freer ST; Larson V; Luty BA; Marrone T; Rose PW
Proteins; 2001 Dec; 45(4):456-70. PubMed ID: 11746693
[TBL] [Abstract][Full Text] [Related]
3. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
4. Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.
Nachman J; Gish G; Virag C; Pawson T; Pomès R; Pai E
PLoS One; 2010 Jun; 5(6):e11215. PubMed ID: 20574521
[TBL] [Abstract][Full Text] [Related]
5. Prediction of phosphotyrosine signaling networks using a scoring matrix-assisted ligand identification approach.
Li L; Wu C; Huang H; Zhang K; Gan J; Li SS
Nucleic Acids Res; 2008 Jun; 36(10):3263-73. PubMed ID: 18424801
[TBL] [Abstract][Full Text] [Related]
6. Prediction of binding sites of peptide recognition domains: an application on Grb2 and SAP SH2 domains.
McLaughlin WA; Hou T; Wang W
J Mol Biol; 2006 Apr; 357(4):1322-34. PubMed ID: 16476443
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
Hou T; Chen K; McLaughlin WA; Lu B; Wang W
PLoS Comput Biol; 2006 Jan; 2(1):e1. PubMed ID: 16446784
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
9. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
11. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
[TBL] [Abstract][Full Text] [Related]
12. Constraining binding hot spots: NMR and molecular dynamics simulations provide a structural explanation for enthalpy-entropy compensation in SH2-ligand binding.
Ward JM; Gorenstein NM; Tian J; Martin SF; Post CB
J Am Chem Soc; 2010 Aug; 132(32):11058-70. PubMed ID: 20698672
[TBL] [Abstract][Full Text] [Related]
13. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
[TBL] [Abstract][Full Text] [Related]
14. An Efficient Semi-supervised Learning Approach to Predict SH2 Domain Mediated Interactions.
Kundu K; Backofen R
Methods Mol Biol; 2017; 1555():83-97. PubMed ID: 28092029
[TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
[TBL] [Abstract][Full Text] [Related]
16. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains.
Zhou Y; Abagyan R
Fold Des; 1998; 3(6):513-22. PubMed ID: 9889165
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive binary interaction mapping of τ phosphotyrosine sites with SH2 domains in the human genome: Implications for the rational design of self-inhibitory phosphopeptides to target τ hyperphosphorylation signaling in Alzheimer's Disease.
Bao Z; Liu J; Fu J
Amino Acids; 2022 Jun; 54(6):859-875. PubMed ID: 35622130
[TBL] [Abstract][Full Text] [Related]
18. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
20. Reverse Binding Mode of Phosphotyrosine Peptides with SH2 Protein.
Wang R; Leung PYM; Huang F; Tang Q; Kaneko T; Huang M; Li Z; Li SSC; Wang Y; Xia J
Biochemistry; 2018 Sep; 57(35):5257-5269. PubMed ID: 30091902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
